FOXP3 and B-cell non-Hodgkin lymphoma: Investigators have found that co-injection of MSCs with neoplastic (A20) B cells promotes B cell lymphoma growth in the lacrimal glands of immunocompetent mice and were associated with marked increased in CD4+ forkhead box P3 (FoxP3) + T cells and myeloid-derived suppressor cells (5).